United States Drug Coated Stent Market was valued at USD 1.89 Billion in 2022 and is projected to reach USD 3.02 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030.
Start
The U.S. Drug-Coated Stent Market Is Experiencing Significant Growth, Driven By Advancements In Medical Technology And An Increasing Prevalence Of Cardiovascular Diseases. Drug-Coated Stents, Also Known As Drug-Eluting Stents (Des), Are Specialized Devices Used To Keep Narrowed Arteries Open, Releasing Medication To Prevent Restenosis. This Market'S Expansion Is Influenced By Various Factors, Including Technological Innovations, Regulatory Approvals, And Evolving Industry Requirements.
Market Overview
In 2023, The Global Drug-Coated Stent Market Was Valued At Approximately Usd 6.5 Billion And Is Projected To Reach Usd 12.3 Billion By 2032, Reflecting A Compound Annual Growth Rate (Cagr) Of 7.1%. This Growth Is Primarily Attributed To The Rising Incidence Of Cardiovascular Diseases And The Adoption Of Minimally Invasive Procedures. The U.S. Market, Being A Significant Contributor, Benefits From Advanced Healthcare Infrastructure And A High Demand For Innovative Medical Devices.
Types Of Drug-Coated Stents
The Market Offers A Variety Of Drug-Coated Stents, Each Designed To Cater To Specific Patient Needs And Clinical Scenarios:
Everolimus-Coated Stents: Known For Their Efficacy In Reducing Restenosis Rates, These Stents Are Widely Used In Clinical Practice.
Zotarolimus-Coated Stents: These Stents Release Zotarolimus, An Immunosuppressive Drug, To Prevent Neointimal Hyperplasia.
Ridaforolimus-Coated Stents: Incorporating Ridaforolimus, These Stents Aim To Inhibit Smooth Muscle Cell Proliferation.
Synergy Coated Stents: Featuring A Bioresorbable Polymer Coating, These Stents Promote Healing And Reduce Inflammation.
Orsiro Coated Stents: Combining Biocompatibility With Effective Drug Delivery, These Stents Are Designed For Optimal Patient Outcomes.
Industry Requirements And Demand
The Demand For Drug-Coated Stents In The U.S. Is Influenced By Several Industry Requirements:
Regulatory Compliance: Manufacturers Must Adhere To Stringent Fda Regulations To Ensure The Safety And Efficacy Of Stents. Recent Approvals, Such As The Biofreedom Drug Coated Coronary Stent System By Biosensors International, Highlight The Industry'S Commitment To Meeting Regulatory Standards.
Technological Advancements: Continuous Research And Development Efforts Are Focused On Improving Stent Designs, Materials, And Drug Formulations To Enhance Patient Outcomes And Reduce Complications.
Cost-Effectiveness: Healthcare Providers Seek Stents That Offer A Balance Between Cost And Clinical Benefits, Influencing Purchasing Decisions And Market Dynamics.
Training And Education: Ensuring That Healthcare Professionals Are Adequately Trained In The Deployment Of Drug-Coated Stents Is Crucial For Optimal Patient Care And The Adoption Of New Technologies.
The U.S. Drug-Coated Stent Market Continues To Evolve, Driven By Technological Innovations And A Focus On Meeting Industry Requirements. As The Demand For Advanced Cardiovascular Treatments Grows, Manufacturers And Healthcare Providers Must Collaborate To Address The Challenges And Opportunities Within This Dynamic Market.
Get an In-Depth Research Analysis of the US Drug Coated Stent Market Size And Forecast [2025-2032]
Â
Biosensors International
Abbott Laboratories
Advantec Vascular
B. Braun
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Drug Coated Stent Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Drug Coated Stent Market
Balloon-Expandable Drug-Coated Stents
Self-Expanding Drug-Coated Stents
Polymer-Coated Stents
Non-Polymer-Coated Stents
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
Sirolimus-Eluting Stents
Paclitaxel-Eluting Stents
Zotarolimus-Eluting Stents
Coronary Artery Disease
Peripheral Artery Disease
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Drug Coated Stent Market Research Analysis
1. Introduction of the US Drug Coated Stent Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Drug Coated Stent Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Drug Coated Stent Market, By Type
6. US Drug Coated Stent Market, By Application
7. US Drug Coated Stent Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Drug Coated Stent Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/